Organisations can apply for a share of £5 million inclusive of VAT. This is to deliver innovations addressing key drug related overdose priorities across two competitions.
Award: Share of up to £5 million
Opens: 31st Jan 2023
Closes: 21st Apr 2023
These are Small Business Research Initiative (SBRI) competitions funded by the Office for Life Sciences (OLS) and the Scottish Health Industry Partnership (SHIP).
These competitions form part of the UK Addiction Healthcare Mission, UK Life Sciences Vision and Scottish Government National Mission to reduce drug related deaths and harm.
OLS and SHIP are investing up to £5 million including VAT, across the two competitions. Their purpose is to develop disruptive, innovative solutions that focus on detecting, responding to, and intervening in, early acute risk of non-fatal and fatal overdose.
Competition 1 – SBRI: Overdose detection, response and intervention feasibility
This competition is for feasibility studies for projects which have not yet reached prototype development.
This is phase 1 of a potential 2 phase competition. The decision to proceed to phase 2 will depend on success in phase 1 and the assessment of a separate application.
Competition 2 – SBRI: Overdose detection, response and intervention demonstration (this competition)
This competition is for projects with technology already at an advanced stage of development, and near ready to be deployed in a real-world environment.
This is a single-phase competition.
The aim of this competition is to speed up and improve the detection of, response to and intervention in potentially fatal overdoses using innovative digital technologies and therapeutic solutions.
Projects can focus on one or more of the following priorities:
This list is not intended to be exhaustive.
The potential innovative mechanisms and technologies you can use, include but are not limited to:
SBRI encourage proposals that bring together sector specialists and include a co-design and co-production element with the expertise of people:
SBRI will give preference to proposals that demonstrate how innovative solutions can be formally accepted for use across the 4 UK health systems. For example, through obtaining necessary regulatory compliance and approvals.
Your project can focus on one or more of the following themes:
Prototype development and evaluation
Your project can include prototyping, demonstrating, piloting, testing and validation of new or improved products, processes or services in environments representative of real-life operating conditions.
The primary objective is to make further technical improvements on products, processes or services that are not substantially set and provide a demonstration of the prototype in a representative environment.
As part of your application, you must engage with a suitable research and innovation partner to serve as a ‘test bed’. The test bed research partner is required to develop your proposed solution, gain relevant clinical and non-clinical advice and to determine the extent of required work within the test bed.
Suitable test bed research partners could include the NHS Scotland Regional Test Beds, or equivalents located in England, Wales or Northern Ireland, for example:
You can also propose any other suitable UK based alternative.
To lead a project, you can:
Contracts will be awarded to a single legal entity only. However, if you can justify subcontracting components of the work, you can engage specialists or advisers. This work will still be the responsibility of the main contractor.
Organisations are advised to only lead on one application per technology identifying a suitable research partner.
Organisations are asked to confirm if they would be willing to work with other research partners.
This competition will not fund any procurement, commercial, business development or supply chain activity with any Russian or Belarusian entity as lead or subcontractor. This includes any goods or services originating from a Russian or Belarusian source.
Innovate UK will not fund projects that:
A total of up to £5 million, inclusive of VAT, is allocated across the two competitions.
The total funding available for the competition can change.
The funders have the right to:
For this Overdose detection, response and intervention – demonstration competition, R&D contracts will be up to £500,000 inclusive of VAT, to develop a prototype and undertake field testing for up to 12 months.
The contract is completed at the end of the funded project and the successful organisation is expected to pursue commercialisation of their solution.
Value Added Tax (VAT)
You must select whether you are VAT registered before entering your project costs.
VAT is the responsibility of the invoicing business. We will not provide any further advice and suggest you seek independent advice from HMRC.
If you select you are VAT registered, you must enter your project costs exclusive of VAT. As part of the application process VAT will be automatically calculated and added to your project cost total. Your total project costs must not exceed £500,000.
Not VAT registered
If you select you are not VAT registered, you must enter your project costs exclusive of VAT and no VAT will be added. You will not be able to increase total project costs to cover VAT later should you become VAT registered. Your total project costs must not exceed £500,000.
Research and development
Your application must have at least 50% of the contract value attributed directly and exclusively to R&D services, including solution exploration and design. R&D can also include prototyping and field-testing the product or service. This lets you incorporate the results of your exploration and design and demonstrate that you can produce in quantity to acceptable quality standards.
R&D does not include:
SBRI competitions involve procurement of R&D services at a fair market value and are not subject to subsidy control criteria that typically apply to grant funding.
Book an appointment to speak to one of our advisors to discuss your eligibility to apply for this Grant Funding opportunity.